Prova Storytel gratis i 30 dagar Ett universum fyllt av ljudböcker, klicka här för att komma igång

The Lancet Oncology in conversation with

En podcast av: The Lancet Group

Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more

Our American listeners can also listen to The Lancet Oncology in conversation with at our American site

207 Avsnitt

Ariana Znaor on cancer surveillance in the Eastern Mediterranean region
Publicerades 2025-03-03

207 Avsnitt

Ariana Znaor on cancer surveillance in the Eastern Mediterranean region

Ian Tannock on Common Sense Oncology principles for phase 3 randomised clinical trials

Yannick Romero on the changing landscape of national cancer control plans

M Saiful Huq and Mostafa Aziz Sumon on the series Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries

Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma

Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination

May Abdel-Wahab and Andrew Scott on The Lancet Oncology Commission on Radiotherapy and Theranostics

Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02)

Emmy Boerrigter on dose selection of novel anticancer drugs

Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations

Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment

James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean

Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials

Maria Kyrgiou on innovations in gynaecological cancers and global disparities

Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers

Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer

Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma

Neerja Bhatla on a new quadrivalent HPV vaccine

Chandra Are on the Lancet Oncology Commission on Global Cancer Surgery

Philipp Karschnia on tissue sampling and processing during resection of diffuse intracranial glioma

Wanda Cui on measuring ovarian toxicity

Ticiana Leal on Tumour Treating Fields

Xuesong Han on cancer diagnosis during the COVID-19 pandemic in the USA

Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma

Madeline Pe on the SISAQOL initiative

Kadia Petricca and Joyce Kambugu on access to essential cancer medicines for children

Mark Lythgoe on UK oncology drug approval after Brexit

Janet Brown on the phase 2/3 STAR trial

Valerie Speirs on biomarkers in male breast cancer

Sameer Bakhshi on sex disparities in childhood cancer in India

Shankar Siva on radiotherapy for primary renal cell carcinoma

Mark Lawler and Richard Sullivan on the European Groundshot

Samar Alhomoud on challenges for cancer control in the Gulf region

Inge Marie Svane on mRNA vaccines for cancer treatment

Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer

Ignace Vergote and Maria Kyrgiou on gynaecological cancers

David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer

Wilfred Ngwa, Beatrice Wiafe-Addai, and David Kerr on cancer in sub-Saharan Africa

Georgios Lyratzopoulos on emergency presentation

Lisa Iezzoni on disabilities and cancer, and Jordan Marchak on mental health problems in young cancer survivors

Rosie Bradley on early-stage breast cancer treatment

Yi-Long Wu and Caicun Zhou on non-small-cell lung cancer

Rebecca Fitzgerald on Barrett's oesophagus surveillance

Elysia Alvarez on adolescent and young adult cancer

Aju Mathew on cancer care in India

David Pinato on cancer patients who recovered from SARS-CoV-2 infection

James Glasbey on the effect of lockdowns on cancer surgery

Manju Sengar and Christopher Booth on essential cancer drugs

Susannah Stanway, Richard Cowan, Danielle Rodin, and Miriam Mutebi on helping with cancer control in LMICs

Harriet Rumgay on the burden of cancer attributable to alcohol

Rafael Cardoso and Hermann Brenner on colorectal cancer

Takayuki Yoshino on the DESTINY-CRC01 trial

Roberto Orecchia on the ELIOT trial

Hedvig Hricak, Andrew Scott, Rifat Atun, and May Abdel-Wahab on nuclear medicine

Ariana Znaor on breast and cervical cancer in the former Soviet Union

Sathira Perera on global cancer surgery

Short-course radiotherapy for advanced rectal cancer

The crucial role of oncology nurses in cancer care

The effect of climate change on cancer control

Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer

Peptide receptor radionuclide therapy for neuroendocrine tumours

Larotrectinib in patients with TRK fusion-positive solid tumours

The future of radiotheranostics

International standards for the analysis of patient-reported outcomes in cancer trials

Presenting symptoms of cancer and stage at diagnosis

Global public and philanthropic investment in childhood cancer research

Cervical cancer in India

Oropharyngeal squamous cell carcinoma

Cancer in small island nations

Advances in radioimmunotherapy

International Neoadjuvant Melanoma Consortium

IMWG consensus on imaging in plasma cell disorders

Digital oncology

Choosing Wisely India

Paediatric vertebral radiotherapy

Malignant plural mesothelioma

CAR T-cell therapy

Cervical cancer screening in older women

Palliative care in oncology